Health matters newsletter: The whole truth about weight-loss drugs
On 'weight loss' drugs and their impacts, the scorching heat and sleep apnoea, what persists after a Covid-19 infection, AI in healthcare, and more.
Universally, a certain class of drugs have come to be superstars in recent times. The GLP-1 class of drugs, with their capacity for weight loss, though originally conceived and developed for diabetes, has suddenly become the toast of the season, for one reason - their weight loss properties. With celebrities like Elon Musk flaunting their use of these drugs, semaglutide and more recently, tirzepatide, reached homes even before the results of rigorous control trials were ready for publication. While over the months, the trials have indicated good overall results, both for weight loss and blood sugar control, a new field study offers a more realistic estimate of how these GLP-1 receptor agonists work in real time.
A recent study, done in the U.S. indicated that these New 'weight-loss' drugs have lower impact in real life compared to clinical trial results. In a paper published in the journal Obesity, Hamlet Gasoyan et al accessed electronic health record data from a large health system in Ohio and Florida to identify adults with overweight or obesity without type 2 diabetes who started with injectable semaglutide or tirzepatide between 2021 and 2023. The researchers observed that treatment discontinuation and use of lower maintenance dosages might reduce the likelihood of achieving clinically-meaningful weight reduction in patients on these drugs.
This is something that diabetologists in India agreed with, instinctively. In a randomised control trial, there is incentive and constant reminders to take the drugs. In the real world setting, when patients have to pay for their drugs out of their own pocket and without a rigorous reminder, or because of the side effects that they cannot tolerate, a number of people discontinue treatment. And drugs work only as long as they are taken.
Further on this topic, Dr. V. Mohan, Chennai-based diabetologist discusses on The Health Wrap by The Hindu about who are ideal candidates for these drugs, whether a regimen must be followed and deciding the appropriate dosage levels for people on GLP-1 drugs. Zubeda Hamid and I discuss other issues too, including good and bad bacteria, migration and climate change, not to mention a giraffe's cervical structure. Do tune in, to listen.
Having lived out another May, a torrid summer, there is no doubt that a climate crisis is upon us. The WHO says 2024 was the warmest year on record – but the heat is far from over. A new report from the World Meteorological Organization (WMO) warns that global temperatures will likely continue rising, with an 80 per cent chance that at least one year between now and 2029 will be even hotter. Climate emergency is a health crisis 'that is already killing us,' the WHO adds.
Delhi and other parts of northern and central India were severely impacted as temperatures soared beyond bearable. Our stories give you a clear picture: Delhi under 'red alert' as mercury soars beyond 45 degrees C; severe heatwave conditions to persist; Blistering heat continues in north, central India; hills scorch. Meanwhile, we also reported on a study which found that Warmer climate could make sleep apnoea more severe, common. Sleep apnoea, a condition characterised by having trouble breathing properly while sleeping, could become more common and severe in a warmer future, a new study has found. Obstructive Sleep Apnoea (OSA) is a common sleep disorder, estimated to affect about a billion worldwide. The condition occurs when muscles in the throat narrow the airways, impacting breathing and blood oxygen levels during sleep.The findings, published in the journal Nature Communications, show that one's chances of experiencing sleep apnoea could spike by 45 per cent on days with higher temperatures.
Meanwhile, the government is mulling whether to restrict the temperature range on air conditioners. Vasudevan Mukunth, here, explains the Science behind setting the right temperature on the air conditioner.
Last week, a very important document was launched, something we would do well to heed. With the launch of HelpAge India's national report, ahead of World Elder Abuse Awareness Day, which is marked on June 15, on intergenerational dynamics, it is clear that we need to create better bonds with senior citizens and also encourage more digital literacy. For a greying nation, we need to pay more attention to the health and social support needs of the elderly, bringing it back into the DNA of the culture we live in.
We do our periodic dip stick test for COVID-19, profiling various developments in the area, even as the number of cases is going up slowly. Dr. M.S. Seshadri and Dr. T. Jacob John explain what the current Resurgence of COVID 19 means for India. They argue that the recent number of COVID-19 cases, reported as nearly 7,000, reflects the greater volume of testing, not the true magnitude of infection or disease in the population.
More than four years since the COVID-19 pandemic began, the disease remains a global health concern — not because of new surges but because of what persists. Do read about a genetics study that linked a lung gene to known, recorded post-COVID sequelae. Bindu Shajan Perappadan also focuses on the same angle, reminding readers of the the threat of deep vein thrombosis associated with COVID.
We also endeavour to point out areas of hope and positivity, as it is so important in health care. Health is as much about wellness and recovery as it is about disease and pain. There is some hope with reports that Novavax's COVID-flu combo vaccine which showed strong immune response in trial.
In other news, Jacob Koshy reports that SII and DNDi have partnered to expand human trials for dengue treatment. Hopefully, we will have better dengue treatment protocols soon. Again in India, here is a model that could be replicated, as Rajasthan's cash plus model pushes up early breastfeeding rate, dietary diversity among new mothers.
The big minus about treating cancer is the way the treatment causes general toxicity, as it tars even healthy tissue with the same brush. Here, there seems to be a solution to this: In a first, arc therapy beats tricky cancer while sparing nearby tissue.
Afshan Yasmeen reported that Karnataka's MMR was steadily decline; it has reduced to 58 per lakh live births in 2020-22. Great news, indeed.
It was also the week we discussed India's falling fertility rates. As per a UN report, fertility rate drops below replacement level, Purnima Sah wrote. According to the UNFPA, millions of people in India are not able to realise their real fertility goals. Calling this the 'real' crisis, and not overpopulation or underpopulation, the report calls for the pursuit of reproductive agency — a person's ability to make free and informed choices about sex, contraception and starting a family — in a changing world. Replacement-level fertility, commonly defined as 2.1 births per woman, is the rate at which a population size remains constant from one generation to the next.
The recent World Health Assembly has created a turning point for skin health, explained Dr. Monisha Madhumitha. Here's what the WHA's landmark resolution on skin diseases means for the world.
Moving on to a key component of health care, we had articles that discussed the role of AI in the health sector this past week.
While Sayantan Datta asked How safe AI is in healthcare depends on the humans of healthcare, Dr. Aravinda C. took the argument further discussing the promise and pitfalls of evaluating AI tools with mismatched yardsticks. Dr. V. Viju Wilben turned our attention to how technology can help, at a time when most city roads are perennially clogged with traffic jams, to reclaim the Golden Hour, and save lives.
In the tailpiece segment, reverse ageing steals the spotlight. If only it were possible! But Anirban Mukhopadhyay brought hope, with the article. Common molecule offers clue to making old muscles young again. As we age, it gets harder to recover from a fall, injury or even a tough workout because the body's muscle-repair system starts to falter. Muscle stem cells (MuSCs), the in-house repair crew, stop dividing and rebuilding tissue, losing their ability to respond to damage. A study in Cell Stem Cell on June 12 suggested this decline may be reversible. The key isn't some futuristic therapy but a molecule already used in hospitals today -prostaglandin E2.
We had a very healthy, and robust explainers section this week.
Sophie Davies, in The Conversation wrote of Diverticular disease
Sreedevi Jayachandran explained Tourette syndrome and its management
Serena Josephine M.'s story in our 'All You Need to Know About' series was on hernias
Dr. Steve Thomas wrote two fine pieces on the occasion of blood donation day. Do click on the links to read them: Our body's crimson tide: understanding blood disorders and the vital role of blood donation and Our body's crimson tide: the evolving treatment landscape in haematology
Athira Elssa Johnson wrote on The risks of undiagnosed gall bladder stones: doctors call for awareness, timely treatment, how to read the tongue as a measure of health; and filed yet another story in our monthly Nobel winners series: This one on Sir Ronald Ross and his contributions towards malaria control
Dr. Sathyanarayana L.D. elaborated on a little-explored subject, in connection with Brain Tumour Day (June 8) on aphasia, or the loss of language, after brain tumour surgery.
Our In Focus podcast discussed the risks of the government's proposed 'mixopathy' move
If you have some extra time on your hands, also read:
C. Maya: Living donor transplants thrive as Kerala turns its face away from deceased donor organ donations
Serena Josephine M.: Many private hospitals in T.N. hit by acute shortage of Hepatitis B vaccine
Indian-origin physician Bobby Mukkamala sworn in as American Medical Association president
Science Quiz: On eye health
–
For many more health stories, head to our health page and subscribe to the health newsletter here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
an hour ago
- India Today
Court orders preservation of dead man's semen as mother seeks it for lineage
The Bombay High Court has directed a Mumbai-based fertility centre to preserve the frozen semen of a 21-year-old cancer patient who died earlier this year, after his mother approached the court seeking to use it to continue the family's mother, a resident of Santacruz in Mumbai, told the court that her son had been diagnosed with Ewing sarcoma — a rare form of bone and soft tissue cancer. Before starting chemotherapy, his oncologist advised the family to freeze his semen as the aggressive treatment could affect his to the mother's petition, the family was confident the young man would recover, but were unaware that he had independently signed a consent form instructing the fertility centre to destroy his semen if he did not survive. The family, which now comprises only women following the deaths of the father and uncle, said the son was the sole male heir. The 21-year-old passed away on February 16 this year. Amid their bereavement, the family requested the fertility centre to transfer the preserved semen to a facility in Gujarat for further medical advice. However, the centre refused without a legal directive, citing the man's signed with no other option, the mother wrote to various government offices but received no response. She then filed a petition in the Bombay High plea came up before Justice Manish Pitale, who observed that the matter raises significant questions about how semen or gametes should be handled after the donor's death under the Assisted Reproductive Technology (Regulation) Act, 2021, and its rules. "This becomes particularly significant in the present case, for the reason that the deceased, being the son of the petitioner, was unmarried at the time of his death," Justice Pitale for the Union of India, Advocate Yashodeep Deshmukh referred to a pre-ART Act judgement of the Delhi High Court, where frozen semen was handed over to the parents of a person. However, he pointed out that unlike that case, the young man here had explicitly opted for disposal of his samples after his court also took note that in the Delhi High Court judgement, directions had been issued to the Ministry of Health and Family Welfare to consider framing appropriate laws or guidelines for posthumous sought time to verify whether any such guidelines now exist under the ART to ensure that the mother's plea does not become futile, the Bombay High Court ordered the fertility centre to preserve the frozen semen until the matter is decided.- EndsMust Watch
Time of India
2 hours ago
- Time of India
Duncan Hines parent Conagra Brands says it will phase out artificial colors
HighlightsConagra Brands, the parent company of Duncan Hines and Slim Jim, announced it will discontinue the use of artificial colors in its frozen foods by the end of this year and across its entire portfolio by the end of 2027. The company will not offer products containing artificial colors to K-12 schools starting from the 2026-2027 school year, aligning with similar commitments made by Kraft Heinz and General Mills. The federal government has increased scrutiny on artificial colors, with a recent ban on the dye Red 3 and plans to eliminate synthetic dyes by the end of 2026, relying on voluntary efforts from the food industry. Conagra Brands , the parent company of Duncan Hines , Slim Jim and other brands, is the latest big food company to say it's discontinuing the use of artificial dyes. In a statement released Wednesday - the same day as a similar statement from Nestle - Chicago-based Conagra said it will remove artificial colors from its frozen foods by the end of this year. Conagra's frozen brands include Marie Callender's, Healthy Choice and Birds Eye. Conagra said it won't offer products containing artificial colors to K-12 schools by the beginning of the 2026-2027 school year, and it will work to discontinue artificial dyes across its entire portfolio by the end of 2027. Kraft Heinz and General Mills made similar pledges earlier this month. The federal government has stepped up its scrutiny of artificial colors in recent months. In January, days before President Donald Trump took office, the U.S. regulators banned the dye called Red 3 from the nation's food supply, nearly 35 years after it was barred from cosmetics because of potential cancer risk. In April, Trump's Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said the agency would take steps to eliminate synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry . Many of Conagra's products already make a point of using natural dyes . On a jar of Vlasic kosher pickle spears, Conagra notes that they're colored with turmeric, not the synthetic Yellow 5. For the cheesy color in its frozen vegetable sides or its Orville Redenbacher popcorn, Conagra uses annatto, a plant extract. But some of Conagra's products still rely on synthetic colors. Duncan Hines' Comstock County Cherry pie filling uses Red 40, for example, while its Creamy Strawberries n' Cream Frosting uses both Red 40 and Yellow 5. Conagra's Swiss Miss Butterscotch pudding contains Yellow 6, Red 40 and Blue 1.
Hans India
2 hours ago
- Hans India
Zero-dose children: India's immunisation coverage surpasses global averages, says Centre
Even as the latest Lancet paper marked India among eight countries with a high burden of zero-dose children, those who had never received a routine childhood vaccine, the Union government on Saturday said that the country's large population size, and high vaccination coverage rate must be considered when making such comparisons. The government noted that 'India's antigen-wise immunisation coverage surpasses global averages across all antigens'. In other words, the vaccination strategy deployed in India is targeted against antigens, which can trigger an immune response resisting pathogens (like a virus or bacteria). The global study, led by the Institute for Health Metrics and Evaluation at the University of Washington, US, showed that in 2023, more than half of the world's 15.7 million unvaccinated children were living in just eight countries. These were primarily in sub-Saharan Africa (53 per cent) and South Asia (13 per cent): Nigeria, India, the Democratic Republic of Congo, Ethiopia, Somalia, Sudan, Indonesia, and Brazil. The government stated that with continued, sustained efforts and intensified implementation of vaccination drives and campaigns across the country, the percentage of zero-dose children in India has actually declined to 0.06 per cent in 2024 from 0.11 per cent in 2023. The numbers, which positioned India as a global exemplar in child health, have also been acknowledged by the UN Inter-agency Group for Child Mortality Estimation in its 2024 report, the Ministry of Health and Family Welfare said. Further, citing the WUNEIC report 2023, the Ministry explained that the national coverage for Diphtheria-tetanus-pertussis (DTP) -- DTP1 and DTP3 -- ranks among the highest compared to other countries with the largest number of zero-dose children. According to WUENIC 2023, India, with a high population size and socio-geographical diversity, National DTP-1 (Penta-1) has a coverage of 93 per cent, which is 2.47 crore out of 2.65 crore infants have been vaccinated, even though during the equivalent period, which is significantly higher than Nigeria's 70 per cent. There is a commensurate decrease in dropout percentage from DTP-1 to DTP-3, from 7 per cent in 2013 to 2 per cent in 2023, and an increase in coverage of Measles from 83 per cent in 2013 to 93 per cent in 2023. The comparative results of countries on zero dose children as a percentage of the total population shows that Yemen (1.68 per cent), Sudan (1.45 per cent), Angola (1.1 per cent), Afghanistan (1.1 per cent), Nigeria (0.98 per cent), DR Congo (0.82 per cent), Ethiopia (0.72 per cent), Indonesia (0.23 per cent), Pakistan (0.16 per cent) have far more zero dose children as a percentage of their population compared to India's 0.11 per cent during 2023 as per the last Wuneic report released. Thus, 'any comparison of India with any other countries with high burden zero dose children needs to take into consideration India's large population size and high vaccination coverage rate,' the Ministry said. 'Therefore, any interpretation or analysis based on isolated factors does not lend credence to the country's progress on its immunisation programme,' it added. The Ministry said that India's unwavering commitment to immunisation is evident in its elimination of polio in 2014 and maternal and neonatal tetanus in 2015, and the roll-out of the measles-rubella campaign in 2025.
